Does RANIBIZUMAB Cause Blindness transient? 100 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Blindness transient have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.7% of all adverse event reports for RANIBIZUMAB.
100
Reports of Blindness transient with RANIBIZUMAB
0.7%
of all RANIBIZUMAB reports
0
Deaths
32
Hospitalizations
How Dangerous Is Blindness transient From RANIBIZUMAB?
Of the 100 reports, 32 (32.0%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Blindness transient Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Blindness transient?
AFLIBERCEPT (987)
ADALIMUMAB (200)
METFORMIN (153)
DIMETHYL (119)
INTERFERON BETA-1A (102)
NATALIZUMAB (101)
BROLUCIZUMAB-DBLL (99)
FINGOLIMOD (89)
BEVACIZUMAB (72)
DUPILUMAB (59)
Which RANIBIZUMAB Alternatives Have Lower Blindness transient Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE